No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Annexon Biosciences Strengthens Board for Strategic Growth
Express News | Annexon Expands Board of Directors With Appointment of Commercial Executive William “Bj” Jones
Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $12 to $30
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Annexon Biosciences' ANX005: Strong Buy Rating Backed by Promising Efficacy and Sales Potential